Health values and prospect theory

Medical Decision Making

Volumn 19, Issue 3, 1999, Pages 344-352

  Treadwell, Jonathan R ^a   Lenert, Leslie A ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cost effectiveness analysis; Decision analysis; Health values; Patient preferences; Prospect theory; Quality of life; Utility theory

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH BEHAVIOR; HEALTH STATUS; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PATIENT ATTITUDE; QUALITY OF LIFE;

ATTITUDE TO HEALTH; CHOICE BEHAVIOR; DECISION MAKING; DECISION SUPPORT TECHNIQUES; HUMANS; PATIENT PARTICIPATION; QUALITY OF LIFE;

EID: 0032989328     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9901900313     Document Type: Article

References (52)

1. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;4:263-91.
2. Weinstein M, Fineberg H, Elstein A. Clinical Decision Analysis. Philadelphia, PA: W. B. Saunders, 1980.
3. von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. 2nd ed. Princeton, NJ: Princeton University Press, 1953.
4. Wakker P, Stiggelbout A. Explaining distortions in utility elicitation through the rank-dependent model for risky choices. Med Decis Making. 1995;15:180-6.
5. Wakker PP, Deneffe D. Eliciting von Neumann-Morgenstern utilities when probabilities are distored or unknown. Manage Sci. 1996;42:1131-50.
6. Bayoumi A, Redelmeier D. Correcting distorted utilities: an application of cumulative prospect theory to medical economics [abstr]. Med Decis Making. 1996;16:457.
7. Allais M. Le comportement de l'homme rationnel devant le risque: critique des postulates et axiomes de l'ecole americaine. Econometrica. 1953;21:503-46.
8. Ellsberg D. Risk, ambiguity, and the Savage axioms. Quarterly Journal of Economics. 1961;75:643-69.
9. McNeil B, Pauker SG, Tversky A. On the framing of medical decisions. In: Bell DE, Raiffa H, Tversky A (eds.). Decision Making: Descriptive, Normative, and Prescriptive Interactions. Cambridge, U.K.: Cambridge University Press, 1988.
10. Tversky A, Wakker PP. Advances in prospect theory: cumulative representation of uncertainty. J Risk Uncertainty. 1992; 5:297-323.
11. Wakker PP, Tversky A. An axiomatization of Cumulative Prospect Theory. J Risk Uncertainty. 1993;7:147-76.
12. Markowitz H. The utility of wealth. J. Political Economy. 1952;60:151-8.
13. Nease RF. Risk attitude in gambles involving length of life: aspirations, variations, and ruminations. Med Decis Making. 1994;14:201-3.
14. Howard RA. Life and death decision analysis. Stanford, CA: Department of Engineering-Economic Systems, Stanford University, 1979.
15. Gaskin DJ, Kong J, Meropol NJ, Yabroff KR, Weaver C, Schulman KA. Treatment choices by seriously ill patients: the health stock risk adjustment model. Med Decis Making. 1998; 18:84-94.
16. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31: 697-704.
17. Boyd NF, Sutherland H, Cummings BJ. The selection of primary therapy for patients with cancer of the rectum. Med Decis Making. 1982;2:354.
18. Boyd, NF, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ. Whose utilities for decision analysis? Med Decis Making. 1990;10:58-67.
19. Dolan P. The effect of experience of illness on health state valuations. J Clin Epidemiol. 1996;49:551-64.
20. Llewellyn-Thomas HA, Thiel EC, Clark RM. Patients versus surrogates: whose opinion counts on ethics review panels? Clin Res. 1989;37:501-5.
21. Tsevat J, Cook EF, Green ML, et al. Health values of the seriously ill. SUPPORT investigators. Ann Intern Med. 1995;122: 514-20.
22. Rosser R, Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol. 1978;7:347-58.
23. Llewellyn-Thomas HA, Sutherland HJ, Tritchler DL, et al. Benign and malignant breast disease: the relationship between women's health status and health values. Med Decis Making. 1991;11:180-8.
24. Richardson J, Nord E. The importance of perspective in the measurement of quality-adjusted life years. Med Decis Making. 1997;17:33-41.
25. Nord E. The person-trade-off approach to valuing health care programs. Med Decis Making. 1995;15:201-8.
26. Lenert LA, Treadwell JR, Schwartz C. Associations between health status and utilities: implications for health policy. Med Care. 1999;37.
27. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-33.
28. Christensen-Szalanski JJJ. Discount functions and the measurement of patients values: women's decisions during childbirth. Med Decis Making. 1984;4:47-58.
29. Llewellyn-Thomas HA, Sutherland HJ, Ciampi A, Etezadi-Amoli, J, Boyd NF, Till JE. The assessment of values in laryngeal cancer: reliability of measurements methods. J Chronic Dis. 1984;37:283-91.
30. Llewellyn-Thomas HA, Sutherland HJ, Thiel EC. Do patients' evaluations of a future health state change when they actually enter that state? Med Care. 1993;31:1002-12.
31. O'Connor AM, Boyd NF, Warde P, Stolbach L, Till JE. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis. 1987;40:811-8.
32. McNeil BJ, Pauker SG, Sox HC Jr, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 1982;306:1259-62.
33. Meyerowitz BE, Chaiken, S. The effect of message framing on breast self-examination attitudes, intentions, and behavior. J Pers Soc Psychol. 1987;52:500-10.
34. Nord E. Methods for quality adjustment of life years. Soc Sci Med. 1992;34:559-69.
35. O'Connor AM, Boyd NF, Tritchler DL, Kriukov Y, Sutherland H, Till JE. Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables. Med Decis Making. 1985;5:453-63.
36. O'Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization [published erratum appears in J Clin Epidemiol. 1997;50:747-8]. J Clin Epidemiol. 1996;49: 1271-6.
37. Pauker SG, Pauker SP, McNeil BJ. The effect of private atti-tudes on public policy. Prenatal screening for neural tube defects as a prototype. Med Decis Making. 1981;1:103-14.
38. Slovic P, Fischhoff B, Lichtenstein S. Facts versus fears: understanding perceived risk. In: Kahneman D, Slovic P, Tversky A (eds). Judgment under Uncertainty: Heuristics and Biases. Cambridge, U.K.: Cambridge University Press, 1982: 463-89.
39. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211:453-8.
40. Hughes KK. Decision making by patients with breast cancer: the role of information in treatment selection. Oncol Nurs Forum. 1993;20:623-8.
41. Siminoff LA, Fetting JH. Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions [see comments]. Med Decis Making. 1989;9:262-71.
42. O'Connor AM. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989;42:119-26.
43. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978;299:1397-401.
44. Tsevat J, Dawson NV, Matchar DB. Assessing quality of life and preferences in the seriously ill using utility theory. J Clin Epidemiol. 1990;43suppl:73S-77S.
45. Miyamoto JM, Eraker SA. A multiplicative model of the utility of survival duration and health quality. J Exp Psychol Gen. 1988;117:3-20.
46. Miyamoto JM, Eraker SA. Parametric models of the utility of survival duration: tests of axioms in a generic utility framework. Org Behav Hum Decis Proc. 1989;44:166-202.
47. Verhoef LC, de Haan AF, van Daal WA. Risk attitude in gambles with years of life: empirical support for prospect theory. Med Decis Making. 1994;14:194-200.
48. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
49. Helfand M. Book review of Gold MR, et al. (eds). Cost Effectiveness in Health and Medicine. Med Decis Making. 1998; 18:240-3.
50. Ubel P, Loewenstein G, Scanlon D, Kamlet M. Individual utilities are inconsistent with rationing choices: a partial explanation of why Oregon's cost-effectiveness list failed. Med Decis Making. 1996;16:108-16.
51. Harsanyi JC. Cardinal utility in welfare economics and in the theory of risk taking. J Political Economy. 1953;61:434-5.
52. Harsanyi JC. Cardinal welfare, individualistic ethics, and interpersonal comparisons of utility J Economic Literature. 1955;63:309-21.